Findings from type 2 diabetes research indicate that sleep is both a predictor of onset and a correlate of disease progression. However, the role sleep plays in glucose regulation and daytime functioning in youth with type 1 diabetes mellitus (T1DM) has not been systematically investigated. Nonetheless, preliminary findings have supported that various sleep parameters are strongly correlated to health-related and neurobehavioral outcomes in youth with T1DM. This suggests that improving sleep might reduce morbidity. A critical step in developing evidencebased guidelines regarding sleep in diabetes management is to first determine that sleep modification in natural settings is possible (i.e., instructing youth to have a healthy sleep opportunity leads to more total sleep time) and that an increased sleep duration impacts disease and psychosocial outcomes in these youth. This article describes the background, design, and feasibility of an ongoing randomized clinical trial that aims to examine if increasing sleep relative to youth's own sleep routines affects glucose control and daytime functioning.
Diabetes and Sleep Insufficiency
Current recommendations for sleep duration are that school-age youth through age 13 should obtain 9-11 hours per night and older adolescents (14+ years) should obtain 8-10 hours of sleep per night for optimal health and wellbeing ( Hirshkowitz et al., 2015 ) . Tarokh, Carskadon, and Achermann (2012) demonstrated that adolescents have a biological need for at least nine hours of sleep per night. However, nearly 2/3 of youth fail to obtain the recommended sleep duration ( Perfect, Levine-Donnerstein, Archbold, Goodwin, & Quan, 2014 ) . Higher rates of sleep disturbances in youth with T1DM may be evident as early as the preschool years ( Monaghan, Herbert, Cogen, & Streisand, 2012 ) and continue into adolescence ( Caruso et al., 2014 ) . With regard to sleep duration, studies have supported that high rates of inadequate total sleep time (TST) exist amongst youth with T1DM ( Estrada, Danielson, Drum, & Lipton, 2012 ; Jaser & Ellis, 2016 ; Perfect, 2014 ) . Although Monaghan found that the average TST (11.69 hours inclusive of naps) for 24 preschoolers with T1DM fell within the recommended range (10 to 13 hours), considerable variability existed and most children did not achieve the upper limit. Very few studies have reported objectively measured sleep duration in school-age youth with T1DM relative to those without diabetes; studies using polysomnography (PSG) revealed that youth with T1DM had shorter sleep duration than healthy peers/controls ( Matyka, Crawford, Wiggs, Dunger, & Stores, 2000 ; Perfect et al., 2012 ; Pillar et al., 2003 ) . Using actigraphy, we have previously reported that the average weekly sleep duration was less than seven hours for a sample of 10 to 16 year olds with T1DM ( Perfect et al., 2012 ) .
Despite some evidence of insufficient sleep, it is unclear whether sleep has a direct impact on glycemic control. One study ( Jaser & Ellis, 2016 ) did not yield a significant correlation between TST and glucose control, but sleep quality and HbA1c were related among male adolescents. Our previous cross-sectional study supported that shorter sleep duration related to higher HbA1c levels in 10 to 16 year olds ( Perfect, 2014 ) . The mechanisms may be due to sympathetic activation, increased stress hormones (cortisol), or increased inflammation. Beyond the physiological underpinnings of shortened sleep, sleep insufficiency may impact adherence in diabetes management. Effective management of diabetes requires day-to-day decision making, emotional and behavioral regulation, attention, planning, comprehension, and memory ( McNally, Rohan, Pendley, Delamater, & Drotar, 2010 ) . Data from healthy populations have indicated that insufficient sleep has been associated with impairment in these skills ( Dewald, Meijer, Oort, Kerkohof, & Bögels, 2010 ; Perfect et al., 2014 ; Steenari et al., 2003 ) . In this regard, Jaser and Ellis (2016) did find a significant association between sleep duration and blood glucose checks.
Experimental Manipulation of Sleep
Despite the plausibility of sleep's role in glucose regulation and skills that foster adherence to treatment, the American Diabetes Association's ( ADA, 2016 ) current standards of care in the management of T1DM are devoid of recommendations for sleep, most likely because of the lack of evidence demonstrating a causal relationship between better sleep and improved outcomes for youth with T1DM. In contrast, the potential impact of insufficient sleep on glucose and insulin sensitivity (body's response to insulin; Matsuda & DeFronzo, 1999 ) has been demonstrated within adult experimental protocols employing a moderate sleep restriction condition (generally 4 to 5 hours ranging from one night to multiple weeks; Buxton et al., 2010 ; Buxton et al., 2012 ; Reynolds et al., 2012 ; Spiegel, Leproult, & Cauter, 1999 ; van Leeuwen et al., 2010 ) and adults with T1DM ( Donga et al., 2010 ) . Furthermore, clinical trials with adult samples have demonstrated that extending sleep over six weeks to twelve months in natural environments is feasible ( Cizza et al., 2011 ; Leproult, Deliens, Gilson, & Peigneux, 2015 ) . Further, in non-obese adults, the additional sleep contributed to improved insulin sensitivity and glucose levels ( Leproult et al., 2015 ) as well as neurocognition ( Lucassen et al., 2014 ) .
No such experimental sleep manipulation studies have been published on youth with T1DM. However, healthy youth and youth with asthma can follow a home-based sleep modification protocol, including sleep extension instructions ( Beebe et al., 2008 ; Beebe, Rose, & Amin, 2010 ; Beebe et al., 2013 ; Fallone, Acebo, Seifer, & Carskadon, 2002 ; 2005 ; Gruber, Cassoff, Frenette, Wiebe, & Carrier, 2012 ; Meltzer et al., 2015 ; Sadeh, Gruber, & Raviv, 2003 ; Jiang et al., 2011 ) . These studies found that within a short timeframe, decreases in sleep duration demonstrated negative effects on cognition, behavior, and diet ( Beebe, et al., 2010 ; Beebe et al., 2013 ; Fallone et al., 2005 ; Gruber et al., 2012 ; Jiang et al., 2011 ; Sadeh et al., 2003 ) . Such sleep restriction studies have merit in that they establish that changing sleep duration results in adverse physiological or psychological outcomes. However, because youth with T1DM are frequently sleep deficient, a more clinically important question is whether increasing sleep duration produces measureable positive outcomes. In this regard, new studies have highlighted potential benefits of youth obtaining additional sleep (i.e., recommending a specific 'healthy sleep opportunity,' or time in bed, in anticipation that a participant will increase TST), including improvements with attention, memory, problem-solving, emotional regulation, and depression ( Dewald-Kaufman, Oort, & Meijer, 2013 ; 2014 ; Gruber et al., 2012 ; Sadeh et al., 2003 ) .
Study Aims
Although there is a relative lack of knowledge pertaining to the association between T1DM and sleep, a number of studies have suggested that an adverse relationship exists. There is evidence of a causal link between inadequate sleep and endocrine functioning in adults with and without diabetes and neurobehavior in non-medically involved youth, but due to maturational changes that occur during adolescence, the burden of a complex medical regimen, and the physiological underpinnings of T1DM, successful execution and benefit in this pediatric population remains to be determined. Thus, to truly determine the causal contribution of sleep in the health and functioning of youth with T1DM, it is necessary to perform a randomized control trial (RCT) to demonstrate that a sleep intervention results in a change in a T1DM outcome. The ultimate goal of this line of research is to demonstrate improvements in Hemoglobin A1c (HbA1c), which is the "gold standard" measurement of glucose control and a metric of average glucose over approximately a three month period ( ADA, 2016 ) . This would necessitate a sleep intervention that is unprecedented in pediatric diabetes research. Given the costs and complexity of multi-site, large scale-RCTs, particularly ones that are of longer duration, we undertook a RCT to examine a brief pediatric sleep extension intervention to establish a well-developed set of procedures, ascertain perceptions of youth with T1DM and their families regarding the intervention, and obtain preliminary evidence of effect (i.e., short-term efficacy). This paper describes the design and feasibility of data collected in the context of this RCT. We address considerations including (1) the sufficiency in the number of youth who evidenced inadequate sleep duration and were willing to participate; (2) the development of the study procedures and adherence to our sleep modification consultation instructions; and (3) feedback reported by study participants.
Method Participants
This study reports data from 79 participants who were enrolled as part of a larger, ongoing RCT examining the efficacy of a brief sleep extension intervention on glucose control and neurobehavioral functioning in youth with T1DM. Participants, between the ages of 10-16 with a confirmed diagnosis of T1DM as defined by the ADA, were recruited exclusively from one pediatric endocrinology clinic in the Southwest region of the United States. To be included, child participants were required to speak, read, and understand English, and have at least one caregiver willing to participate. Exclusion criteria included (1) psychiatric, cognitive, genetic (e.g., Down syndrome, Prader-Willi syndrome, Fragile X), or neurological conditions (e.g., epilepsy) that could significantly impact sleep, neurobehavioral performance, glucose control, or participation; and (2) hospitalization within one month of enrollment. Based on recommended sleep durations, participants were eligible for randomization if they slept <9.5 hours for 10 to 13 year olds and <9 hours for 14+ year olds ( Hirshkowitz et al., 2015 ; Tarokh et al., 2012 ) .
Measures
To show the depth of the overall protocol in the context of all study procedures, including a comprehensive neurobehavioral evaluation, we provide a Supplemental online table that includes the measures we administered, including the respondent perspective, and descriptions of the information yielded from them. Continuous glucose monitors (CGMs) were used to assess glucose levels and variability as these devices are recognized for capturing short-term, day-to-day fluctuations in glycemic control. We used the iPro-CGM (Medtronics, Minneapolis, MN), which is an FDA-approved blinded device, validated for use with children under 18 to track glucose levels every 5 minutes ( Agus, Alexander, Wolfsdorf, 2010 ; Al-Ansary et al., 2011 ; Alleyn et al., 2011 ) . Retrospective CGM recordings have the benefit of not influencing diabetes management during clinical trials ( Muchmore, Sharp, & Vaughn, 2011 ) . It is placed subcutaneously with the recorder attached to the sensor. Youth were instructed to continue with their diabetes regimen, but for CGM calibration purposes, asked to obtain finger-stick blood glucose levels at least four times a day with the provided meter and strips. Using the glucose logs, participants were asked to record their carbohydrate intake, exercise intensity, insulin adjustments, and meter readings. The self-reported meter values were used as a backup in case of meter failure or in instances when an alternative meter had been used for which values were not available. During one night of the Naturalistic Sleep Period, each child underwent a home-based PSG. The PSG was recorded using the Compumedics Somté system (Abbotsford, Victoria, Australia). PSG allows for ascertainment of sleep stages (N1, N2, N3, REM) via electroencephalogram (EEG), sleep-disordered breathing via respiratory channels, sleep quality, and sleep duration ( Iber, Acoli-Israel, Chesson, & Quan, 2007 ) . Concurrent with the CGM, participants wore an actigraph (Actiwatch-Spectrum, Philips Respironics), which is a wristwatch-sized device that records the frequency of movement to estimate sleep-wake patterns in 30 second intervals. Actigraphy data have been found to correlate with PSG data ( Iber, Ancoli-Israel, Chesson, & Quan, 2007 ; Ancoli-Israel et al., 2003 ; Meltzer, Montgomery-Downs, Isana, & Walsh, 2012 ) , be valid for use with children and adolescents ( Ancoli-Israel et al., 2003 ; Meltzer, et al., 2012 ) , and allow for continuous serial data collection over several days.
At the final study visit (Neurobehavioral Evaluation #2), participants and caregivers were asked to complete an exit survey and provide the study team with feedback about their experience. Questions inquired about the ease of the child extending his/her sleep (sleep extension condition only), how successful the child was perceived to be at extending or maintaining his/her sleep, how helpful the sleep consultation was in modifying the child's sleep, and how likely the child was to continue the assigned sleep schedule after the study ended.
Procedure
The study was approved by the local human subject protection program. Prior to initiating the RCT, we ran nine participants through all the anticipated procedures to solidify the sleep extension intervention components, determine potential barriers to implementation, and select viable study endpoints. To collect data using a multi-setting, multi-informant, and multi-method approach, the study typically involved three clinic visits, one home visit, and two school visits during the 12-day participation. These occurred in the following order: (1) consent; (2) home-based sleep study; (3) school visit #1; (4) end of Naturalistic Sleep period/Neurobehavioral Evaluation #1/start of Sleep Modification period; (5) school visit #2; and (6) end of Sleep Modification period/Neurobehavioral Evaluation #2. Participants' baseline, referred to as the Naturalistic Sleep period, involved tracking sleep and glucose for approximately six days as well as a battery of neurobehavioral measures. For the Sleep Modification period, also lasting approximately six days, participants were randomly assigned to one of two conditions: Sleep Extension or Fixed Sleep Duration.
Recruitment-Our primary method of recruitment occurred at potential participants' regularly scheduled clinic visits in which they were given information about the study. Participants were initially asked by clinic staff if they would grant permission for a research team member to describe the study. Patients were given the option to decline, schedule, provide information for follow-up, or participate immediately if an opening existed. If a research team member was not available, clinic staff asked the potential participant to leave contact information. As this study was occurring over multiple years and to preserve privacy, no identifying information was retained for patients who did not provide contact information. Clinic staff or research team members recorded basic demographic information and patient-provide reason for refusal for families who opted not to meet with a researcher, give contact information, or enroll after hearing about the study.
Initial intake (consent visit)-Enrollment began with a consent visit during which participants provided written assent, had an actigraph placed on their non-dominant wrist, and had a CGM inserted. Guardians signed a consent document and a release of information for school data. They were also provided meters and strips (50), a glucose log, and a sleep diary.
Naturalistic Sleep period (baseline)-We instructed participants to follow their typical school week and weekend sleep schedules, but to wake up at the time they would for school if they were absent. At the end of the Naturalistic Sleep period, participants returned their devices, completed forms, and underwent Neurobehavioral Evaluation #1. This evaluation lasted approximately 3.5 hours during which a parent spent about 30 to 45 minutes completing questionnaires. The evaluator, trained on neurobehavioral assessments as part of a doctoral program of study, was blinded to the Sleep Modification condition until after the evaluation was completed. We strived to balance team members in the number of Naturalistic and Sleep Modification evaluations they completed; no team member completed both evaluations for any participant.
Sleep Modification period (intervention)-After completing the neurobehavioral measures, a research team member computed average Naturalistic sleep duration using data from the sleep diary and actigraphy. As with other sleep modification studies ( Beebe et al., 2008 ; Fallone et al., 2002 ; Gruber et al., 2012 ; Leproult, Deliens, Gilson, & Peigneux, 2015 ; Lucassen et al., 2014 ) that have incorporated both methods of assessing sleep duration, we established a protocol to use a combination of the two to mitigate inaccuracies in actigraphy due to variability in children's motoric activity and the unknown credibility of the sleep diary ( Short, Gradisar, Lack, Wright, & Carskadon, 2012 ) . We also focused on time in bed increases (considering the light data from actigraphy to determine whether an adolescent attempted to follow the instructions (i.e., modify their sleep/comply with sleep schedule). In the small number of cases for which the diary and actigraphy were widely discrepant, the research team member conferred with another team member and/or PI to determine if the actigraphy data should be used for TST ( Ashworth et al., 2015 ) .
The team member then provided a newly initialized actigraph and CGM, as well as a new sleep diary, glucose log, and more glucose strips. At that time, the evaluator learned the assignment of the participants' Sleep Modification condition (e.g., Sleep Extension or Fixed Sleep Duration) and revealed to the participant and caregiver. To increase power, efficiency, and reduce bias, random assignment included stratification based on Tanner Stage Groups [pre-pubertal (Stage I), early puberty (Stages II-III), and late puberty (Stage IV-V; Kernan, Viscoli, Makuch, Brass, Horwitz, 1999 ; Kahan & Morris, 2012 ) ]. The groupings are consistent with research on insulin resistance and pubertal circadian rhythm changes ( Moran et al., 1999 ).
The consultation intervention, which lasted approximately 20 minutes, was delivered by the same individual who completed the evaluation. For both conditions, interventionists reviewed actigraphy and diary data with the student in the presence of at least one caregiver. The review included patterns, bedtimes and wake-times plus sleep onset and offset, sleep disruptions (e.g., longer latency and frequent/long awakenings), and light exposure (e.g., blue light suggesting technology usage). At the end of the Sleep Modification week, the interventionist met with families to review data. Once again, if the veracity of the diary was in question, the interventionists used discretion and/or consulted with the supervising PI to determine what information should be conveyed to families about their child's estimated TST change from one week to the next.
Sleep extension-To improve the likelihood of obtaining a healthy sleep opportunity, the research team member and family worked collaboratively to address factors that interfere with sleep onset and quality sleep. Table 1 provides the general target areas of the consultation for the Sleep Extension participants, which involved instructing participants to increase their time in bed to up to 10 hours or one hour more than their Naturalistic Sleep, whichever was greater ( Beebe et al., 2008 ; Fallone, et al., 2002 ) . At the consultation, the trained research team member asked participants about their daily routines (particularly afterschool/evening) and focused on behaviors/conditions that were relevant for the child. This consultation was based on procedures used in previous sleep modification studies with children and adolescents ( Beebe et al., 2008 ; Beebe et al., 2013 : Fallone et al., 2002 Jiang et al., 2011 ; Sadeh et al., 2003 ) and research demonstrating factors that contribute to sleep disturbances and sleep habits that interfere with daytime functioning, ( Dworak, Schierl, Bruns, & Strüder, 2007 ; Jones, Owens, & Pham, 2013 ; Paterson, Nutt, Ivarsson, Hutson, & Wilson, 2009 ; Perfect et al., 2012 ) . This "prescription" was individualized, reviewed by the adolescent/family, and considered barriers to implementation.
Fixed sleep duration condition-In contrast with other sleep modification studies in natural settings, we did not want to include a 'sleep restriction condition' as research has shown that less sleep is harmful and would be problematic while participants are attending school. Therefore, as most youth were already getting insufficient sleep, we prescribed a duration anchored to their average baseline TST (Naturalistic) to reduce the chances of them getting more sleep during the Sleep Modification period. To balance time with research team members, the consultation was neutral and focused on obstacles to being compliant with the prescribed number of hours.
Mid-week check-in-A mid-week check was conducted in both sleep modification conditions during the six day intervention period. The interventionist (i.e., graduate research assistant who delivered the intervention) called the family to inquire about compliance with the instructions and to determine if any difficulties with the prescribed sleep schedule occurred. If needed to increase adherence to the sleep schedule, the interventionist worked with the family over the phone to troubleshoot problems, reminding them of the strategies discussed in the consultation.
Results

Recruitment and enrollment data
Three-hundred and eighty-eight recruitment attempts (i.e., clinic staff asked the patient permission for a research team member to approach or to provide contact information when a team member was not available) resulted in 180 participants providing contact information, of whom 79 enrolled. These patient inquiries were not necessarily unique cases; some patients may have been informed of the study multiple times. Recruitment for the year stopped due to summer break; thus, there were many potentially eligible participants who could not be scheduled prior to the end of the school year. Additionally, 6.74% of patients who had a scheduled consent visit cancelled or no showed. Among the 79 participants, 34 (44.74%) participants identified as Latino/Latina. Nearly half (48.68%) are females. HbA1c ranged from 5.4% [6 mmol/L) to 12.90% (17.9 mmol/L; mean=9.04% (11.8 mmol/L), SD= 1.91% (.4 mmol/L)]. Sixty participants (76.92%) out of 78 with available HbA1c had values above 7.5%. The mean age of participants was 13.14 years. These characteristics mirror the clinic patient population.
Sleep sufficiency
The overall mean sleep duration of the sample at baseline, as recorded by actigraphy and diary, was 7.46 (SD = .73) and 8.21 (SD = .91) hours, respectively. Although the difference in objectively-measured and self-reported sleep duration constituted a 40 minute difference, the mean actigraphy sleep period (onset to offset) was 8.05 hours (SD = 1.24 hours), which more closely mirrored the diary data. Based on the averaged TST between actigraphy and diary above our TST cutoff, three participants were not randomized (3.80%).
Completion data
None of the 79 participants withdrew from the study. More than 90% of participants were able to use all the equipment following exact study procedures and without any equipment malfunctions for both Naturalistic and Sleep Modification periods. Four participants (5.1%) had missing CGM data during the Naturalistic Sleep period as a result of: replacing the study device with their own CGM device; CGM falling out and participant refusing reinsertion; and not performing enough finger-sticks to calibrate the CGM. During the Sleep Modification period, CGM data were missing for five participants (6.3%) for the following reasons: continuing to use their own CGM (same participant from baseline), continued without reinsertion (same participant from baseline), not enough finger-sticks to calibrate CGM (same participant from baseline), and problems retrieving the data from the CGM. Two participants (2.5%) had missing or insufficient (<3 days) Naturalistic Sleep actigraphy data due to taking off the watch for an extended period of time. In the Sleep Modification period, one participant (1.3%) again, removed the watch resulting in insufficient actigraphy data. We redid two out of four PSGs (prior to the intervention) due to insufficient data.
Sleep modification compliance
Nearly 80% of participants assigned to the Sleep Extension condition obtained at least 15 minutes additional sleep each intervention night than during their Naturalistic Sleep period, with 1/3 of them increasing their sleep duration by over an hour. The average increase in TST was 40.95 (SD = 47.93) minutes; actigraphy showed 28.61 (SD = 37.61) minutes increased from baseline, and diary showed 47.75 (SD = 75.31) minutes increased. In contrast, participants assigned to the Fixed Sleep Duration condition had negligible overall change in sleep duration (3.69 minutes increase for actigraphy and 10.38 increase in diary), with an average of 6.39 minute difference between TST during the Naturalistic and Sleep Modification periods. Collectively, youth in the Sleep Extension condition slept significantly longer than their own baseline and significantly more minutes than youth in the Fixed Sleep Duration condition. Even so, one in five youth in the Sleep Extension condition failed to increase their sleep by at least 15 minutes, whereas one in four in the Fixed Sleep Duration condition ended up increasing their sleep by at least that long (See Table 2 ). Table 3 provides comments regarding facilitators and barriers to modifying sleep schedules. For youth participants randomized to the Sleep Extension condition and their parents, 60-66% reported that it was somewhat to very difficult to extend their sleep, respectively. When asked how likely participants were to continue with the sleep schedule used for the study, 55% of youth in the control condition said they were very likely to somewhat likely to continue, 22.5% were somewhat to very unlikely to continue, and 15% were unsure if they would continue. The sleep extension group was less likely to endorse a desire to continue their prescribed sleep schedule as 45.5% reported being very likely to somewhat likely; 23.8% being somewhat to very unlikely, and 17.9% were unsure if they would continue. Caregivers also answered a question asking how helpful they perceived the sleep consultation to in successfully modifying their child's sleep. Overall, most of the caregivers in the Sleep Extension group felt the sleep consultation was somewhat or very helpful (25.6% and 51.3%, respectively). The control group did not differ greatly in their viewing of the sleep consultation as helpful.
Participant feedback
Discussion
Given that 60% to 80% of youth with T1DM experience suboptimal control ( Moore, Hackworth, Hamilton, Northam, & Cameron, 2013 ) , a critical need exists to improve standard clinical care and interventions in this population. The current study demonstrates that it is possible to implement a sleep extension intervention in a cohort of youth with T1DM who participate in a RCT. Our primary objective of the overarching study was to determine the role that sleep had in health and psychosocial outcomes in youth with T1DM. We propose that sleep should be an integral part of diabetes management; and therefore, studies are needed to demonstrate that increasing sleep duration produces measureable, positive outcomes reversing the effects of prior self-imposed sleep restriction.
The data presented in this article pertained to the feasibility of implementing a sleep extension intervention in youth with T1DM, a population known to have difficulty with adherence to health behaviors. Overall, similar to prior sleep extension studies in natural environments, 80% of youth with T1DM followed the sleep extension instructions for one week. They did so despite the fact that the majority reported that the prescribed sleep schedule was 'somewhat' or 'very' difficult. One caution is that only 45.5% indicated they would be at least somewhat likely to continue the sleep schedule. It is possible that it could become easier as youth acclimate to the earlier bedtimes over time. Nonetheless, researchers employing interventions with the intention to impact glycemic control and daytime functioning should determine exactly what strategies are needed to ensure sustainability.
The data show that youth are willing to monitor and extend their sleep, at least in the short term. If youth increased sleep by as little as 15 minutes per night, they would obtain 7.5 hours additional sleep per month, and 90 more hours of sleep in a year. The benefit of different "doses" of additional sleep has not been tested. However, put in perspective, certain pharmacological treatments deemed to be clinically efficacious to target sleep problems produce a ~15 minute increase in TST ( Cizza, Piaggi, Rother, & Csako, 2014 ; Roth, Hull, Lankford, Rosenberg, & Scharf, 2008 ) .
Design Considerations, Future Interventions, and Consideration of Sustainability
The study components were developed based on previously published studies ( Beebe et al., 2008 ; Fallone et al., 2002 ; Gruber et al., 2012 ; Meltzer et al., 2015 ; Sadeh et al., 2003 ) . One distinction for some of those studies is that their primary aim was to experimentally manipulate sleep (both restricted and extended) to show contrasting effects of sleep on outcomes of interest. However, very few studies aimed to use sleep as an intervention that is meant to be long lasting.
Data from the Fixed Sleep Duration (control) group suggest that instructions to maintain consistent sleep duration may effectively prevent inadvertent additional sleep during a sleep modification study, though some may experience less sleep and others may exhibit an increase. As responses to our exit surveys indicated, one possible explanation for this finding is that these families were expecting to find out how their adolescents could get more sleep (even though we did not state this as the purpose). The impact of participants' expectations entering a sleep extension study was illustrated in another recent trial in which adults with obesity experienced improvements in overall health even prior to randomization ( Cizza, Piaggi, Rother, & Csako, 2014 ) . One solution may be to not prime participants that the sole focus of the study is related to sleep or to do a full cross-over design in which all participants experience both experimental conditions. Further, obtaining more consistent sleep, albeit still below recommendations for the age group, may have some benefit. Thus, a control group in a study of longer duration (i.e., 3 months to mirror quarterly visits typical of youth with T1DM) may be further differentiated if youth were allowed to maintain their natural sleep patterns.
As we refine the sleep modification condition and move toward sustainability, we are considering the tools that might help participants change their lifestyle to allow for more sleep opportunity and quality, such as training or referrals to engage in basic mind-body techniques (e.g., self-hypnosis, mindfulness, yoga; Perfect & Smith, 2016 ) that have been shown to be helpful in reducing stress and/or insomnia. Further, we may need to employ motivational interviewing techniques to work with participants to adopt healthier sleep habits ( Cassoff, Rushani, Gruber, & Knauper, 2014 ) . In addition, an alternative approach to sleep extension, as employed by other investigators, ( Dewald et al., 2013 ; 2014 ) , would be to instruct adolescents to increase their sleep in 5-minute increments rather than increased time in bed all at once. This may be necessary for "treatment-resistant" youth who need to gradually adjust their circadian rhythm. However, many youth show day-to-day fluctuations in sleep that far exceed five minutes, suggesting that less cautious adjustments produce change. We found the bigger challenge was modifying routines to enable youth to spend more time in bed rather than with how long it took them to fall asleep.
Another consideration is the method of measuring sleep duration. The PSG data provide an objective metric of sleep duration but does not capture night-to-night variability in TST ( Perfect et al., 2012 ) . The actigraphy is a validated measure in children, but has previously been reported to potentially underestimate adolescent sleep ( Short et al., 2012 ) . However, sleep diary relies on the adolescent both being compliant with completing it as well as being accurate in the information provided. Some adolescents may also overestimate as well. In this regard, the rest interval (i.e., time in bed) may more closely align with the self-reported sleep times. Thus, our determination of sleep duration at each time point and the difference between the two may be less precise than polysomnography. Consequently, for studies that examine sleep duration change as the outcome or as a mediating or moderating effect on an outcome (e.g., glucose), use off multiple methods of time in bed, sleep duration, and selfreported data should be considered.
Conclusions
At the present time, scarce information exists about sleep and its potential impact on diabetes disease progression or morbidities in youth with T1DM. Yet, youth should spend a significant portion of their day sleeping. Our long-term goal is to determine the role that sleep has in health and neurobehavioral outcomes of youth with T1DM. It is anticipated that the data from the parent RCT will establish the short-term efficacy of providing a healthy sleep opportunity in youth with T1DM, laying the groundwork for future studies examining longer-term sustainability and impact. The strength in our sleep modification consultation approach is that it is relatively brief (~20 minutes for the initial discussion), straightforward, acceptable to most families, and could be integrated into diabetes education. Thus, this study lays the foundation for a large scale RCT to empirically examine if consistently achieving or obtaining close to recommended amounts of sleep leads to clinical improvements in youth with T1DM.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Perfect et al. Page 17 a The percent increased (for Extension group) is based on 16 or more minutes across the Sleep Modification Period; the Percent Not Increased (Fixed Sleep Duration group) is based on sleep not exceeding more than 15 minutes from baseline. Four youth were not randomized due to evidencing sufficient sleep duration at baseline (n = 3) or having a preexisting medical condition discovered after enrollment (n = 1).
